Press Releases

Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock

Jun 19, 2019

Sonoma Pharmaceuticals Sells Animal Health Rights in Asia and Europe for $2.7 million

May 21, 2019

Sonoma Pharmaceuticals Announces Substantial Cost-Cutting Measures

Mar 12, 2019

Sonoma Pharmaceuticals Announces Management Changes

Dec 14, 2018

Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units

Nov 17, 2018

Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019

Nov 8, 2018

Sonoma Pharmaceuticals Announces Second Quarter FY 2019 Financial Results and Conference Call

Nov 1, 2018

Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Keloid Scars

Oct 25, 2018

Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™

Oct 17, 2018

Sonoma Pharmaceuticals Announces Licensing of Antimicrobial Hypochlorous Acid Solution for Management of Blepharitis in the Spanish/Portuguese Markets to Brill Pharma, S.L.

Sep 26, 2018